Long-term outcomes after stenting versus endarterectomy for treatment of symptomatic carotid stenosis: the International Carotid Stenting Study (ICSS) randomised trial.
Détails
ID Serval
serval:BIB_137A944DF230
Type
Article: article d'un périodique ou d'un magazine.
Collection
Publications
Institution
Titre
Long-term outcomes after stenting versus endarterectomy for treatment of symptomatic carotid stenosis: the International Carotid Stenting Study (ICSS) randomised trial.
Périodique
Lancet
Collaborateur⸱rice⸱s
International Carotid Stenting Study investigators
Contributeur⸱rice⸱s
Bamford J., Beard J., Bland M., Bradbury A.W., Brown M.M., Hacke W., Halliday A., Malik I., Mas J.L., McGuire A.J., Sidhu P., Venables G., Brown M.M., Clifton A., Gaines P., Collins R., Molyneux A., Naylor R., Warlow C., Ferro J.M., Thomas D., Coward L., Dobson J., Doig D., Ederle J., Featherstone R.F., Kennedy F., Tindall H., Turner E., McCabe D.J., Wallis A., Brooks M., Chambers B., Chan A., Dewey H., Donnan G., Fell G., Hoare M., Molan M., Roberts A., Roberts N., Beiles B., Bladin C., Clifford C., Grigg M., New G., Bell R., Bower S., Chong W., Holt M., Than P.G., Gett S., Quinn J., Ray M., Wong A., Woodruff P., Foreman R., Schultz D., Scroop R., Atkinson N., Cambell W., Davis S., Field P., Milne P., Mitchell P., Tress B., Yan B., Beasley A., Dunbabin D., Stary D., Walker S., Cras P., Hendriks J.M., Van P., St A.Z., Bosiers M., Deloose K., Brugge-Oostende A.Z., Devos V., Ghekiere J., Vanhooren G., Astarci P., Hammer F., Lacroix V., Peeters A., Verhelst R., Ziekenhuis I., DeJaegher L., Daneault N., Lanthier S., Lebrun L.H., Oliva V., Raymond J., Roy D., Soulez G., Hill M., Hu W., Hudion M., Wong J., Albäck A., Curtze S., Harno H., Ijäs P., Lappalainen K., Lepäntalo M., Meretoja A., Mustanoja S., Paananen T., Railo M., Sairanen T., Soinne L., Vehmas A., Vikatmaa P., Goertler M., Halloul Z., Brennan P., Kelly C., Leahy A., Moroney J., Thornton J., Koelemay M.J., Nederkoorn P.J., Reekers J.A., Roos B.W., Pattynama P.M., van Dijk L.C., van Sambeek H.M., van Urk H., Verhagen H.J., de Bruijn S.F., Keunen R., Knippenberg B., Mosch A., Treurniet F., van Dijk L., van Overhagen H., Wever J., van Hasselt A.A., Zeilstra D.J., Boiten J., Lycklama G.J., Blankensteijn J.D., De Leeuw F.E., Schultze L.J., de Borst G.J., de Kort G.A., Kapelle L.J., Lo T.H., Mali W.P., Moll F., Barber P.A., Bourchier R., Hill A., Holden A., Bakke S.J., Krohg K., Skjelland M., Tennøe B., Bialek P., Biejat Z., Czepiel W., Czlonkowska A., Dowzenko A., Buczek J., Kobayashi A., Lelek M., Polanski J., Kirbis J., Milosevic Z., Zvan B., Blasco J., Chamorro A., Macho J., San L., Branera J., Canovas D., Perendreu J., Björses K., Gottsäter A., Mätzsch T., Sonesson B., Berg B., Delle M., Formgren J., Nyman N., Takolander R., Andersson T., Malmstedt J., Soderman M., Wahlgren C., Wahlgren N., Binaghi S., Hirt L., Michel P., Ruchat P., Bonati L.H., Engelter S.T., Jacob A.L., Kirsch E., Lyrer P.A., Bonvin C., Kalangos A., Lovblad K., Sztajzel R., Higgins N., Kirkpatrick P.J., Martin P., Varty K., Adam D., Bell J., Bradbury A.W., Crowe P., Gannon M., Henderson M.J., Sandler D., Shinton R.A., Scriven J.M., Wilmink T., Egun A., Guta R., Punekar S., Seriki D.M., Thomson G., Brennan J.A., Enevoldson T.P., Gilling-Smith G., Gould D.A., Harris P.L., McWilliams R.G., White R., Prakash K.G., Serracino-Inglott F., Subramanian G., Walker M.G., Clarke M., Davis M., Dixit S.A., Dorman P., Dyker A., Ford G., Golkar A., Lambert D., Lees T., Louw S., Macdonald S., Mendelow A.D., Rodgers H., Stansby G., Wyatt M., Baker T., Jones L., Mitchell D., Munro E., Thornton M., Baker D., Davis N., Hamilton G., McCabe D., Platts A., Tibballs J., Beard J., Cleveland T., Dodd D., Nair R., Nassef A., Nawaz S., Venables G., Belli A., Clifton A., Halliday A., Markus H., McFarland R., Morgan R., Pereira A., Chataway J., Cheshire N., Gibbs R., Hammady M., Jenkins M., Malik I., Wolfe J., Adiseshiah M., Bishop C., Brew S., Jäger R., Kitchen N., Ashleigh R., Butterfield S., Gamble G.E., McCollum C., Nasim A., O'Neill P., Wong J., Edwards R.D., Lees K.R., MacKay A.J., Moss J., Rogers P.
ISSN
1474-547X (Electronic)
ISSN-L
0140-6736
Statut éditorial
Publié
Date de publication
07/02/2015
Peer-reviewed
Oui
Volume
385
Numéro
9967
Pages
529-538
Langue
anglais
Notes
Publication types: Comparative Study ; Journal Article ; Multicenter Study ; Randomized Controlled Trial ; Research Support, Non-U.S. Gov't
Publication Status: ppublish
Publication Status: ppublish
Résumé
Stenting is an alternative to endarterectomy for treatment of carotid artery stenosis, but long-term efficacy is uncertain. We report long-term data from the randomised International Carotid Stenting Study comparison of these treatments.
Patients with symptomatic carotid stenosis were randomly assigned 1:1 to open treatment with stenting or endarterectomy at 50 centres worldwide. Randomisation was computer generated centrally and allocated by telephone call or fax. Major outcomes were assessed by an independent endpoint committee unaware of treatment assignment. The primary endpoint was fatal or disabling stroke in any territory after randomisation to the end of follow-up. Analysis was by intention to treat ([ITT] all patients) and per protocol from 31 days after treatment (all patients in whom assigned treatment was completed). Functional ability was rated with the modified Rankin scale. This study is registered, number ISRCTN25337470.
1713 patients were assigned to stenting (n=855) or endarterectomy (n=858) and followed up for a median of 4·2 years (IQR 3·0-5·2, maximum 10·0). Three patients withdrew immediately and, therefore, the ITT population comprised 1710 patients. The number of fatal or disabling strokes (52 vs 49) and cumulative 5-year risk did not differ significantly between the stenting and endarterectomy groups (6·4% vs 6·5%; hazard ratio [HR] 1·06, 95% CI 0·72-1·57, p=0·77). Any stroke was more frequent in the stenting group than in the endarterectomy group (119 vs 72 events; ITT population, 5-year cumulative risk 15·2% vs 9·4%, HR 1·71, 95% CI 1·28-2·30, p<0·001; per-protocol population, 5-year cumulative risk 8·9% vs 5·8%, 1·53, 1·02-2·31, p=0·04), but were mainly non-disabling strokes. The distribution of modified Rankin scale scores at 1 year, 5 years, or final follow-up did not differ significantly between treatment groups.
Long-term functional outcome and risk of fatal or disabling stroke are similar for stenting and endarterectomy for symptomatic carotid stenosis.
Medical Research Council, Stroke Association, Sanofi-Synthélabo, European Union.
Patients with symptomatic carotid stenosis were randomly assigned 1:1 to open treatment with stenting or endarterectomy at 50 centres worldwide. Randomisation was computer generated centrally and allocated by telephone call or fax. Major outcomes were assessed by an independent endpoint committee unaware of treatment assignment. The primary endpoint was fatal or disabling stroke in any territory after randomisation to the end of follow-up. Analysis was by intention to treat ([ITT] all patients) and per protocol from 31 days after treatment (all patients in whom assigned treatment was completed). Functional ability was rated with the modified Rankin scale. This study is registered, number ISRCTN25337470.
1713 patients were assigned to stenting (n=855) or endarterectomy (n=858) and followed up for a median of 4·2 years (IQR 3·0-5·2, maximum 10·0). Three patients withdrew immediately and, therefore, the ITT population comprised 1710 patients. The number of fatal or disabling strokes (52 vs 49) and cumulative 5-year risk did not differ significantly between the stenting and endarterectomy groups (6·4% vs 6·5%; hazard ratio [HR] 1·06, 95% CI 0·72-1·57, p=0·77). Any stroke was more frequent in the stenting group than in the endarterectomy group (119 vs 72 events; ITT population, 5-year cumulative risk 15·2% vs 9·4%, HR 1·71, 95% CI 1·28-2·30, p<0·001; per-protocol population, 5-year cumulative risk 8·9% vs 5·8%, 1·53, 1·02-2·31, p=0·04), but were mainly non-disabling strokes. The distribution of modified Rankin scale scores at 1 year, 5 years, or final follow-up did not differ significantly between treatment groups.
Long-term functional outcome and risk of fatal or disabling stroke are similar for stenting and endarterectomy for symptomatic carotid stenosis.
Medical Research Council, Stroke Association, Sanofi-Synthélabo, European Union.
Mots-clé
Aged, Carotid Stenosis/complications, Carotid Stenosis/mortality, Carotid Stenosis/therapy, Endarterectomy, Carotid, Female, Follow-Up Studies, Humans, Male, Middle Aged, Recovery of Function, Stents, Stroke/etiology, Stroke/mortality, Stroke/prevention & control, Time Factors, Treatment Outcome
Pubmed
Web of science
Open Access
Oui
Création de la notice
11/06/2021 9:32
Dernière modification de la notice
27/02/2024 7:19
Données d'usage
